Reported Earlier, Zenas BioPharma Prices Upsized $225M Initial Public Offering Of 13,235,294 Common Shares At $17/Share
Portfolio Pulse from Benzinga Newsdesk
Zenas BioPharma has announced the pricing of its upsized $225 million Initial Public Offering (IPO) with 13,235,294 common shares at $17 each. The company's stock will trade on the Nasdaq under the ticker 'ZBIO' starting September 13, 2024.
September 13, 2024 | 5:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zenas BioPharma's IPO is priced at $17 per share, raising $225 million. The stock will trade on Nasdaq under 'ZBIO' starting September 13, 2024.
The IPO pricing and upcoming trading on Nasdaq are significant events for Zenas BioPharma, likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100